AzTrials
AzTrials

Stroke, AcuteNCT05176613

Effects of High Frequency rTMS Combined Motor Learning on Upper Limb Motor Function in Subacute Stroke

A study testing HF-rTMS and ML in people with Stroke, Acute and Hemiplegia, run by Chungnam National University Sejong Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is to present the effect of a program combining high frequency repetitive transcranial magnetic stimulation with motor learning on upper limb motor function and grip strength and activities of daily motion in patients with subacute stroke. Read more about this study

Who is it for?
Any age
Conditions the study is for
Stroke, Acute, Hemiplegia
What is being tested?
HF-rTMS and ML
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
No sites listed yet
Study dates
13 May 2016to 5 Aug 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Hemiplegia from stroke
  • Factors within six months of onset
  • Found to have subcortex damage through diagnoses of magnetic resonance imaging(MRI)
  • Had motor defects on the damaged upper extremities
  • Korean version Mini mental state examination(MMSE-K) score greater than 24 points

Who cannot join

  • Permanent damage such as heart vein
  • Upper limb fractures
  • Neurological damage such as Parkinson's, multiple sclerosis
  • Other reasons limiting upper limb movement
  • Epilepsy or family history of epilepsy
  • wearing a metal tube in skull or pacemaker
  • The lesion at occipital lobe

About this study

Official title: Effects of High Frequency Repetitive Transcranial Magnetic Stimulation Combined Motor Learning on Motor Function and Grip Force for Upper Limbs and Activities of Daily Living in Sub-acute Stroke Patients

This study is to present the effect of a program combining high frequency repetitive transcranial magnetic stimulation with motor learning on upper limb motor function and grip strength and activities of daily motion in patients with subacute stroke.

Purpose : This study was to investigate the effects of high frequency repetitive transcranial magnetic stimulation combined with motor learning effects motor function and grip force for upper limbs and activities of daily living of subacute stroke patients.

Read more

Subjects : Thirty individuals with subacute stroke, satisfying the selection criteria, were selected for this study. Subject were randomly allocated into 14 high frequency repetitive transcarnial magnetic stimulation+motor learning group(experimental group), 16 sham repetitive transcranial magnetic stimulation+motor learning group(control group).

Intervention : 12 sessions, 3d/wk, 4week Studies : upper limb functional assessment(FMA-U/L, BBT), hand grip force assessment(disital hand dynamometer), activities daily of living assessment(K-MBI) Evaluation : 1)pre test 2)post test

Being tested
HF-rTMS, ML, Sham-rTMS
Medical subject headings
Stroke, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HF-rTMSDevice

    Also called High Frequency repetitive Transcranial Magnetic Stimulation(HF-rTMS)

    HF-rTMS stimulated a 70-mm, 8-shaped coil stimulator (The Magstim Company, UK, 2012) on the damaged cerebral cortex. Prior to the application of HF-rTMS, the motor point was identified that stimulates maximum thresholds on the primary motor cortex, causing flexion of the opposite index finger. If the cerebral hemisphere does not show a kinetic response even at the maximum stimulus, the motor point of the opposite hemisphere was found to be symmetrically changed. The intensity of the stimulus was 80% of the resting motor threshold, which means the motor eveked potential above which the first dorsal interosseous muscle can produce 50 μV more than five times out of 10 stimuli. The subject sat on a chair made to hold the head. The stimulation was stimulated at high frequency (10 Hz) for 2 seconds, and the rest was performed for 58 seconds for a total of 200 times for 10 minutes.

  • MLBehavioural

    Also called Motor Learning(ML)

    Motor learning was conducted for two minutes each in five sessions, and the first is the external rotation training to maximum range of the shoulder joint in sitting position. The second method is to stack cups by transferring them from the non-affected side to the affected side by transferring 25 plastic cups of five colors in sitting position with both hands inserted. Third, by pushing and pulling the ball forward and backward with the hands folded, the subject puts a 55 cm healing ball on the table in a sitting position, and pushes and pulls it forward with the upper limb. The fourth method is to insert and remove pegs from the peg board, and the target uses the affected side hand in sitting position. The fifth method is to tear a newspaper, in which the subject overlaps a newspaper on the table in a sitting position, holds it with the non-affected hand, and tears it with the hands of the damage. A total of 10 minutes of motor learning.

  • Sham-rTMSDevice

    Also called Sham repetitive Transcranial Magnetic Stimulation(Sham-rTMS)

    Sham rTMS gives a small intensity of 2% of the resting motor threshold that cannot cause excitement in the motor cortex, and is set to listen to the same frequency of noise as HF-rTMS, and motor learning is applied equally. A total of 20 minutes were applied three times a week for four weeks by applying 10 minutes of Sham rTMS and 10 minutes of motor learning.

Study groups in NCT05176613
Study groupRoleWhat they receive
HF-rTMS and MLExperimentalHigh frequency Repetitive Transcranial Magnetic Stimulation and Motor Learning(Experimental group)
Receives: Device: HF-rTMS; Behavioral: ML
Sham-rTMS and MLSham comparatorSham Repetitive Transcranial Magnetic Stimulation and Motor Learning
Receives: Behavioral: ML; Device: Sham-rTMS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl Meyer Assessment - Upper Limb(FMA-U/L)

    The FMA-U/L score is a tool for evaluating the body's structure, function, and activity level as an evaluation tool for evaluating motor function according to Brunnstrom's recovery phase of Step 6. The minimum value is 0 point and the maximum value is 66 points, and the higher the score, the better the outcome.

    Measured: Change from baseline at the end of four weeks intervention

Secondary outcomes (3)
  1. Box and Block Test(BBT)

    The Box and Block Test(BBT) is device to assess upper limb dexterity in stroke patients

    Measured: Change from baseline at the end of four weeks intervention

  2. Digital hand dynamometer

    The digital hand dynamometer is device to assess hand grip force in stroke patients

    Measured: Change from baseline at the end of four weeks intervention

  3. Korean version of the Modified Barthel Index(K-MBI)

    The Korean version of the Modified Barthel Index (K-MBI) is a functional change sensitive evaluation tool. The minimum value is 0 point and the maximum value is 100 points, and the higher the score, the better the outcome.

    Measured: Change from baseline at the end of four weeks intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jan 2022
  2. Study start13 May 2016
  3. Primary completion29 Jul 2016
  4. Study completion5 Aug 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05176613
Sponsor's protocol ID
2016071HR
Status last verified
Jan 2022
First submitted
2 Dec 2021
Last updated
21 Jan 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing HF-rTMS and ML in people with Stroke, Acute and Hemiplegia, run by Chungnam National University Sejong Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl Meyer Assessment - Upper Limb(FMA-U/L) (time frame: Change from baseline at the end of four weeks intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in